In an attempt to explore modulations in serine/threonine protein kinase activities upon metformin treatment, human IPF lung fibroblasts were subjected to a protein kinase activity assay (PamStation). The gene discussed is MARK2; the disease is idiopathic pulmonary fibrosis.